Reversible Posterior Encephalopathy Syndrome Secondary to Sunitinib

Reversible posterior leukoencephalopathy syndrome (RPLS) is clinical radiologic condition associated with neurological symptoms and cerebral white matter edema. It has been associated with uncontrolled hypertension, eclampsia, immunosuppressants, and more recently the use of antiangiogenic drugs. Su...

Full description

Saved in:
Bibliographic Details
Main Authors: Ricardo Costa, Rubens Costa, Renata Costa, Gilberto Moura de Brito Junior, Henrique Queiroz Cartaxo, Alex Caetano de Barros
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Case Reports in Oncological Medicine
Online Access:http://dx.doi.org/10.1155/2014/952624
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849407935993610240
author Ricardo Costa
Rubens Costa
Renata Costa
Gilberto Moura de Brito Junior
Henrique Queiroz Cartaxo
Alex Caetano de Barros
author_facet Ricardo Costa
Rubens Costa
Renata Costa
Gilberto Moura de Brito Junior
Henrique Queiroz Cartaxo
Alex Caetano de Barros
author_sort Ricardo Costa
collection DOAJ
description Reversible posterior leukoencephalopathy syndrome (RPLS) is clinical radiologic condition associated with neurological symptoms and cerebral white matter edema. It has been associated with uncontrolled hypertension, eclampsia, immunosuppressants, and more recently the use of antiangiogenic drugs. Sunitinib is an inhibitor of the vascular endothelial growth factor receptor widely used in the treatment of metastatic renal cell carcinoma (RCC). We report a rare case of RPLS occurring on therapy with sunitinib in a patient with RCC. Our aim is to highlight the importance of considering RPLS as a diagnostic possibility and to hold sunitinib for RCC patients presenting with neurologic symptoms.
format Article
id doaj-art-4305e30abd2a441eb56b365516f9af16
institution Kabale University
issn 2090-6706
2090-6714
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Case Reports in Oncological Medicine
spelling doaj-art-4305e30abd2a441eb56b365516f9af162025-08-20T03:35:54ZengWileyCase Reports in Oncological Medicine2090-67062090-67142014-01-01201410.1155/2014/952624952624Reversible Posterior Encephalopathy Syndrome Secondary to SunitinibRicardo Costa0Rubens Costa1Renata Costa2Gilberto Moura de Brito Junior3Henrique Queiroz Cartaxo4Alex Caetano de Barros5Department of Oncology, Real Hospital Portugues, 52010 Recife, PE, BrazilCedar Valley Cancer Center, Waterloo, IA 50701, USAAmerican University of the Caribbean, Coral Gables, FL 33134, USADepartment of Radiology, Real Hospital Portugues, 52010 Recife, PE, BrazilDepartment of Radiology, Real Hospital Portugues, 52010 Recife, PE, BrazilDepartment of Neurosurgery, Real Hospital Portugues, 52010 Recife, PE, BrazilReversible posterior leukoencephalopathy syndrome (RPLS) is clinical radiologic condition associated with neurological symptoms and cerebral white matter edema. It has been associated with uncontrolled hypertension, eclampsia, immunosuppressants, and more recently the use of antiangiogenic drugs. Sunitinib is an inhibitor of the vascular endothelial growth factor receptor widely used in the treatment of metastatic renal cell carcinoma (RCC). We report a rare case of RPLS occurring on therapy with sunitinib in a patient with RCC. Our aim is to highlight the importance of considering RPLS as a diagnostic possibility and to hold sunitinib for RCC patients presenting with neurologic symptoms.http://dx.doi.org/10.1155/2014/952624
spellingShingle Ricardo Costa
Rubens Costa
Renata Costa
Gilberto Moura de Brito Junior
Henrique Queiroz Cartaxo
Alex Caetano de Barros
Reversible Posterior Encephalopathy Syndrome Secondary to Sunitinib
Case Reports in Oncological Medicine
title Reversible Posterior Encephalopathy Syndrome Secondary to Sunitinib
title_full Reversible Posterior Encephalopathy Syndrome Secondary to Sunitinib
title_fullStr Reversible Posterior Encephalopathy Syndrome Secondary to Sunitinib
title_full_unstemmed Reversible Posterior Encephalopathy Syndrome Secondary to Sunitinib
title_short Reversible Posterior Encephalopathy Syndrome Secondary to Sunitinib
title_sort reversible posterior encephalopathy syndrome secondary to sunitinib
url http://dx.doi.org/10.1155/2014/952624
work_keys_str_mv AT ricardocosta reversibleposteriorencephalopathysyndromesecondarytosunitinib
AT rubenscosta reversibleposteriorencephalopathysyndromesecondarytosunitinib
AT renatacosta reversibleposteriorencephalopathysyndromesecondarytosunitinib
AT gilbertomouradebritojunior reversibleposteriorencephalopathysyndromesecondarytosunitinib
AT henriquequeirozcartaxo reversibleposteriorencephalopathysyndromesecondarytosunitinib
AT alexcaetanodebarros reversibleposteriorencephalopathysyndromesecondarytosunitinib